nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A lesson in humility: the added values of PET-MRI over PET-CT in detecting malignant hepatic lesions
|
Cohen, Dan |
|
|
50 |
5 |
p. 1423-1433 |
artikel |
2 |
An artificial intelligence-driven image quality assessment system for whole-body [18F]FDG PET/CT
|
Qi, Chi |
|
|
50 |
5 |
p. 1318-1328 |
artikel |
3 |
Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody
|
Stergiou, N. |
|
|
50 |
5 |
p. 1306-1317 |
artikel |
4 |
Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings
|
Völter, Friederike |
|
|
50 |
5 |
p. 1384-1394 |
artikel |
5 |
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index
|
Lindgren Belal, Sarah |
|
|
50 |
5 |
p. 1510-1520 |
artikel |
6 |
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
|
Delker, Astrid |
|
|
50 |
5 |
p. 1280-1290 |
artikel |
7 |
Commentary to “[68 Ga]Ga-FAPI-04 PET/CT on assessing Crohn’s disease intestinal lesions” by Chen and colleagues
|
Lovinfosse, Pierre |
|
|
50 |
5 |
p. 1278-1279 |
artikel |
8 |
Correction to: [18F]mFBG PET‑CT for detection and localisation of neuroblastoma: a prospective pilot study
|
Samim, Atia |
|
|
50 |
5 |
p. 1541 |
artikel |
9 |
Dissemination patterns of Hodgkin lymphoma using a probability network model based on [18F]-FDG PET/CT
|
Mouheb, Mehdi |
|
|
50 |
5 |
p. 1414-1422 |
artikel |
10 |
External validation of an 18F-FDG-PET radiomic model predicting survival after radiotherapy for oropharyngeal cancer
|
Mori, Martina |
|
|
50 |
5 |
p. 1329-1336 |
artikel |
11 |
18F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy
|
Liu, Feng-Tao |
|
|
50 |
5 |
p. 1395-1405 |
artikel |
12 |
[18F]Fluoride PET provides distinct information on disease activity in ankylosing spondylitis as compared to MRI and conventional radiography
|
de Jongh, Jerney |
|
|
50 |
5 |
p. 1351-1359 |
artikel |
13 |
[18F]mFBG PET/CT imaging outperforms MRI and [68 Ga]Ga-DOTA-TOC PET/CT in identifying recurrence pheochromocytoma
|
Suurd, Diederik P. D. |
|
|
50 |
5 |
p. 1538-1540 |
artikel |
14 |
[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
|
Santillo, Alexander F. |
|
|
50 |
5 |
p. 1371-1383 |
artikel |
15 |
[68 Ga]Ga-DOTA-FAPI-04 PET/CT imaging of cirrhosis with hepatocellular carcinoma
|
Zhou, Yue |
|
|
50 |
5 |
p. 1536-1537 |
artikel |
16 |
[68Ga]Ga-FAPI-04 PET/CT on assessing Crohn’s disease intestinal lesions
|
Chen, Liming |
|
|
50 |
5 |
p. 1360-1370 |
artikel |
17 |
Gut microbiota is associated with response to 131I therapy in patients with papillary thyroid carcinoma
|
Zheng, Lei |
|
|
50 |
5 |
p. 1453-1465 |
artikel |
18 |
Head-to-head comparison of [18F]-FDG and [68 Ga]-DOTA-FAPI-04 PET/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer
|
Liu, Shuai |
|
|
50 |
5 |
p. 1521-1531 |
artikel |
19 |
Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study
|
Wang, Guochang |
|
|
50 |
5 |
p. 1499-1509 |
artikel |
20 |
Low-count whole-body PET/MRI restoration: an evaluation of dose reduction spectrum and five state-of-the-art artificial intelligence models
|
Wang, Yan-Ran (Joyce) |
|
|
50 |
5 |
p. 1337-1350 |
artikel |
21 |
Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment—Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial
|
Kitajima, Kazuhiro |
|
|
50 |
5 |
p. 1487-1498 |
artikel |
22 |
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy
|
Winkelmann, Michael |
|
|
50 |
5 |
p. 1406-1413 |
artikel |
23 |
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
|
Fendler, Wolfgang P. |
|
|
50 |
5 |
p. 1466-1486 |
artikel |
24 |
Sensitive and quantitative in vivo analysis of PD-L1 using magnetic particle imaging and imaging-guided immunotherapy
|
Peng, Zhengyao |
|
|
50 |
5 |
p. 1291-1305 |
artikel |
25 |
Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT
|
Korsholm, Kirsten |
|
|
50 |
5 |
p. 1534-1535 |
artikel |
26 |
The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG
|
Shu, Qiaoqiao |
|
|
50 |
5 |
p. 1442-1452 |
artikel |
27 |
The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE
|
Veerman, Chayenne H. A. M. |
|
|
50 |
5 |
p. 1434-1441 |
artikel |
28 |
The epistemology of imaging procedures and reporting
|
Fanti, Stefano |
|
|
50 |
5 |
p. 1275-1277 |
artikel |
29 |
Unique [18F]FDG PET imaging pattern of drug-induced acute generalized exanthematous pustulosis within the SCAR-spectrum
|
Novruzov, E. |
|
|
50 |
5 |
p. 1532-1533 |
artikel |